{"id":"W4221036645","doi":"10.1097/qad.0000000000003218","title":"Ibalizumab shows in-vitro activity against group A and group B HIV-2 clinical isolates","year":2022,"lang":"en","type":"article","venue":"AIDS","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Theratechnologies (Canada)","funders":"","keywords":"Group B; In vitro; Group A; Group (periodic table); Multiple drug resistance; Antibacterial agent","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001620359,0.0003275353,0.0003251555,0.0001571192,0.0001403565,0.0003259939,0.0001611034,0.0002683713,0.001753721],"category_scores_gemma":[0.0004350247,0.0001103539,0.0002198062,0.0001586418,0.0001204009,0.00009438967,0.00009417597,0.0004116452,0.0004413531],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002209145,"about_ca_system_score_gemma":0.0001402423,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00125359,"about_ca_topic_score_gemma":0.001262617,"domain_scores_codex":[0.9997891,0.00006058038,0.00003043446,0.00003299005,0.00004652998,0.00004053582],"domain_scores_gemma":[0.9998043,0.00005837281,0.00004021561,0.00002642699,0.0000391514,0.00003166975],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006727125,0.0002347784,0.003389087,0.0002326671,0.00006039361,0.000103627,0.00004139384,0.0003157135,0.9823939,0.00002396775,0.0002363915,0.01229539],"study_design_scores_gemma":[0.0001983477,0.008273163,0.1075315,0.00007574839,0.0002163191,0.002353058,0.00006837067,0.0015233,0.8702622,0.00005235661,0.009430682,0.00001490074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897876,0.006700377,0.0009229736,0.00009140855,0.00002196573,0.00005172993,0.0003856646,0.00005539796,0.001982997],"genre_scores_gemma":[0.993917,0.001976027,0.001698419,0.00006468293,0.00004153274,0.00003948456,0.001067453,0.00001035844,0.001184952],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001753721,"threshold_uncertainty_score":0.005866766,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02333816314005701,"score_gpt":0.2964773441019996,"score_spread":0.2731391809619426,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}